Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.24
+0.06 (0.97%)
At close: Jun 8, 2026, 4:00 PM EDT
6.32
+0.08 (1.28%)
After-hours: Jun 8, 2026, 5:49 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.08 billion as of June 8, 2026. Its market cap has increased by 36.72% in one year.
Market Cap
1.08B
Enterprise Value
1.22B
1-Year Change
36.72%
Ranking
Category
Stock Price
$6.24
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.08B, an increase of 264.22%. That is a compound annual growth rate of 31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.07B | -18.09% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 1.45B |
| Alvotech | 1.33B |
| Phibro Animal Health | 1.29B |
| Harrow | 1.23B |
| Collegium Pharmaceutical | 1.08B |
| Cronos Group | 1.04B |
| Evotec SE | 1.01B |
| Pacira BioSciences | 899.49M |